Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Concurrent evaluation of novel cardiac biomarkers in ACS: myeloperoxidase, sCD40L, C-reactive protein and risk of death or recurrent ischemia in TACTICS-TIMI 18

Concurrent evaluation of novel cardiac biomarkers in ACS: myeloperoxidase, sCD40L, C-reactive protein and risk of death or recurrent ischemia in TACTICS-TIMI 18. J Am Coll Cardiol. 2006; 47(Suppl A):196A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.